{"id":1172,"date":"2014-10-22T10:39:57","date_gmt":"2014-10-22T08:39:57","guid":{"rendered":"http:\/\/www.remgro.com\/ar2015\/financial-report\/notes-to-the-financial-statements\/"},"modified":"2015-10-16T18:46:35","modified_gmt":"2015-10-16T16:46:35","slug":"notes-to-the-financial-statements","status":"publish","type":"page","link":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/","title":{"rendered":"Notes to the Financial Statements<br\/><small>FOR THE YEAR ENDED 30 JUNE 2015<\/small>"},"content":{"rendered":"<table width=\"100%\">\n<tr>\n<td class=\"notehead\">1.<\/td>\n<td><\/td>\n<td class=\"notehead\" width=\"70%\">BASIS OF PREPARATION<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\" class=\"lead\">The summary consolidated financial statements are prepared in accordance with the requirements of the JSE Limited (JSE) for summary financial statements, and the requirements of the Companies Act applicable to summary financial statements. The JSE requires summary financial statements to be prepared in accordance with the framework concepts and the measurement and recognition requirements of International Financial Reporting Standards (IFRS) and the SAICA Financial Reporting Guides as issued by the Accounting Practices Committee and Financial Pronouncements as issued by the Financial Reporting Standards Council and to also, as a minimum, contain the information required by IAS 34: Interim Financial Reporting.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">The accounting policies applied in the preparation of the consolidated financial statements from which the summary consolidated financial statements were derived are in terms of IFRS and are consistent with those accounting policies applied in the preparation of the previous consolidated annual financial statements, with the exception of the implementation of IFRIC 21: Levies and the amendments to IAS 19: Employee Benefits, IAS 32: Financial Instruments \u0096 Presentation, IAS 36: Impairment of Assets and IAS 39: Financial Instruments \u0096 Novation of derivatives and continuation of hedge accounting. The adoption of these interpretations and amendments had no impact on the results of either the current or prior year. The financial statements have been prepared under the supervision of the Chief Financial Officer, Leon Crouse CA(SA).<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">The summary consolidated financial statements do not contain all the information and disclosures required in the consolidated financial statements. The summary consolidated financial statements have been extracted from the audited consolidated financial statements upon which PricewaterhouseCoopers Inc. has issued an unqualified report. The audited consolidated financial statements and the unqualified audit report are available for inspection at the registered office of the Company.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">2.<\/td>\n<td><\/td>\n<td class=\"notehead\">HEADLINE EARNINGS RECONCILIATION<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold borderbg2\">R million<\/td>\n<td class=\"figboldhead borderlg1 borderrg1\">30 June 2015<\/td>\n<td class=\"figreghead borderlg1 borderrg1 borderlg1\" style=\"text-align:right;\">30 June 2014<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Net profit for the year attributable to equity holders<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">8 715<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">6 917<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Plus\/(minus):<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Net impairment of equity accounted investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">99<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(92)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Impairment of other investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">79<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">80<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Net impairment of property, plant and equipment<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">94<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(5)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Impairment of assets held for sale<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">16<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right; figreg\">\u0096\u2013<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Recycling of foreign currency translation reserves<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">\u0096\u2013<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(32)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>(Profit)\/loss on sale of equity accounted investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(984)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">83<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>(Profit)\/loss on sale of other investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">288<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(98)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Net surplus on disposal of property, plant and equipment<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(5)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(12)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Non-headline earnings items included in equity accounted earnings of equity accounted investments<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(231)<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">(244)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Net surplus on disposal of property, plant and equipment<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(111)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(131)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Profit on the sale of investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(271)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(174)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Net impairment of investments, assets and goodwill<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">213<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">262<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Other non-recurring and capital items<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(62)<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">(201)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Taxation effect of adjustments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(50)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">33<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"borderbg1\">Non-controlling interest<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(25)<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">5<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold borderbg2\">Headline earnings<\/td>\n<td class=\"figbold borderlg1 borderbg2\" style=\"text-align:right;\">7 996<\/td>\n<td style=\"text-align:right;\" class=\"borderbg2 borderrg1 figreg\">6 635<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">3.<\/td>\n<td><\/td>\n<td class=\"notehead\">EARNINGS AND DIVIDENDS<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold borderbg2\">Cents<\/td>\n<td class=\"figboldhead borderlg1 borderrg1\">30 June 2015<\/td>\n<td class=\"figreghead borderlg1 borderrg1 borderlg1\" style=\"text-align:right;\">30 June 2014<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Headline earnings per share<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Basic<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">1 555.0<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">1 292.4<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Diluted<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">1 541.8<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">1 270.3<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Earnings per share<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Basic<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">1 694.9<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">1 347.3<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Diluted<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">1 680.9<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">1 325.7<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Dividends per share<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Ordinary<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">428.00<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">389.00<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Interim<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">169.00<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">156.00<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Final<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">259.00<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">233.00<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">4.<\/td>\n<td><\/td>\n<td class=\"notehead\">INVESTMENTS<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>(Refer annexures <a href=\"http:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/annexure\/\" title=\"ANNEXURE A\" target=\"_blank\">A<\/a> and <a href=\"http:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/annexure-bprincipal-investments-30june2014\/\" title=\"ANNEXURE B\" target=\"_blank\">B<\/a>)<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold borderbg2\">R million<\/td>\n<td class=\"figboldhead borderlg1 borderrg1\">30 June 2015<\/td>\n<td class=\"figreghead borderlg1 borderrg1\" style=\"text-align:right;\">30 June 2014<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Listed investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Associated<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Book value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">41 533<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">36 601<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Market value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">97 926<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">79 734<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Other<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Book value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">902<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">880<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Market value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">902<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">880<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Unlisted investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Associated<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Book value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">11 336<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">11 090<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Directors\u0092 valuation (unaudited)<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">22 516<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">22 497<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Joint ventures<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Book value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">4 962<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">4 478<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013 Directors\u0092 valuation (unaudited)<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">13 295<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">11 063<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Other<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u2013\u0096 Book value<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">1 591<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">1 762<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\u0096\u2013 Directors\u0092 valuation<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">1 591<\/td>\n<td class=\"borderrg1 figreg\" style=\"text-align:right;\">1 762<\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">5.<\/td>\n<td><\/td>\n<td class=\"notehead\">ASSETS and liabilities HELD FOR SALE<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>\n<p class=\"remove-indent\">During June 2015, Remgro entered into an agreement with funds managed by Cinven to acquire 119 923 335 Spire shares (equivalent to a 29.9% shareholding in Spire). In conjunction with the transaction, Remgro and Mediclinic concluded an agreement whereby Mediclinic would acquire Remgro\u0092&#8217;s interest in Spire, subject to a successful Mediclinic rights issue. Total assets and liabilities are<\/p>\n<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(175)<\/td>\n<td class=\"borderbg1 borderrg1 figreg\" style=\"text-align:right;\">\u2013<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Investment<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">8 275<\/td>\n<td class=\"borderbg1 borderrg1 figreg\" style=\"text-align:right;\">\u2013<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Trade and other creditors<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(8 276)<\/td>\n<td class=\"borderbg1 borderrg1 figreg\" style=\"text-align:right;\">\u0096\u2013<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Derivative instruments<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(174)<\/td>\n<td class=\"borderbg1 borderrg1 figreg\" style=\"text-align:right;\">\u0096\u2013<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Various other assets and liabilities classified as held for sale<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">242<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">568<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Assets<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">259<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">754<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Liabilities<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(17)<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">(186)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">67<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">568<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold borderbg2\">R million<\/td>\n<td class=\"figboldhead borderlg1 borderrg1\">30 June 2015<\/td>\n<td class=\"figreghead borderlg1 borderrg1 borderlg1\">30 June 2014<\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\" valign=\"top\">6.<\/td>\n<td><\/td>\n<td class=\"notehead\">Additions to and replacement of property, plant and equipment<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">853<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">852<\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">7.<\/td>\n<td><\/td>\n<td class=\"notehead\">Capital and investment commitments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">5 847<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">1 105<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"borderrg1\">\n<p class=\"remove-indent\">(Including amounts authorised but not yet contracted for, including R4.1 billion in respect of the Mediclinic rights issue)<\/p>\n<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td style=\"text-align:right;\" class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">8.<\/td>\n<td><\/td>\n<td class=\"notehead\">Guarantees and contingent liabilities<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">316<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">306<\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\" valign=\"top\">9.<\/td>\n<td><\/td>\n<td class=\"notehead\">Dividends received from equity accounted investments set off against investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">3 077<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">3 568<\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">10.<\/td>\n<td><\/td>\n<td class=\"notehead\">EQUITY ACCOUNTED INVESTMENTS<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"tablecopybold\">Share of after-tax profit of equity accounted investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\"><\/td>\n<td class=\"borderrg1\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Profit before taking into account impairments, non-recurring and capital items<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">8 332<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">8 584<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Net impairment of investments, assets and goodwill<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(213)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(262)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Profit on the sale of investments<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">271<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">174<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"borderbg1\">Other non-recurring and capital items<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">62<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">201<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Profit before tax and non-controlling interest<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">8 452<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">8 697<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td>Taxation<\/td>\n<td class=\"figbold borderlg1\" style=\"text-align:right;\">(1 129)<\/td>\n<td style=\"text-align:right;\" class=\"borderrg1 figreg\">(1 558)<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td class=\"borderbg1\">Non-controlling interest<\/td>\n<td class=\"figbold borderlg1 borderbg1\" style=\"text-align:right;\">(95)<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">(286)<\/td>\n<\/tr>\n<tr>\n<td class=\"borderbg1\"><\/td>\n<td class=\"borderbg1\"><\/td>\n<td class=\"borderbg1\"><\/td>\n<td class=\"figbold borderlg1 borderbg2\" style=\"text-align:right;\">7 228<\/td>\n<td style=\"text-align:right;\" class=\"borderbg1 borderrg1 figreg\">6 853<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\">11.<\/td>\n<td><\/td>\n<td class=\"notehead\" colspan=\"4\">Fair value remeasurements<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">The following methods and assumptions are used to determine the fair value of each class of financial instruments:<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Financial instruments available-for-sale and investment in money market funds: Fair value is based on quoted market prices or, in the case of unlisted instruments, appropriate valuation methodologies, being discounted cash flow, liquidation valuation or actual net asset value of the investment.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Derivative instruments: The fair value of derivative instruments is determined by using mark-to-market valuations.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Financial instruments measured at fair value are disclosed by level of the following fair value hierarchy:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Level 1 \u0096 Quoted prices (unadjusted) in active markets for identical assets or liabilities;<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Level 2 \u0096 Inputs (other than quoted prices included within level 1) that are observable for the asset or liability, either directly (as prices) or indirectly (derived from prices); and<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Level 3 \u0096 Inputs for the asset or liability that are not based on observable market data (unobservable inputs).<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">The following table illustrates the fair values of financial assets and liabilities that are measured at fair value, by hierarchy level:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\"><img loading=\"lazy\" decoding=\"async\" width=\"852\" height=\"370\" style=\"padding-left:6px;\" src=\"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg\" alt=\"img-1\" class=\"alignnone size-full wp-image-2099\" srcset=\"https:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg 852w, https:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1-300x130.jpg 300w, https:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1-86x37.jpg 86w\" sizes=\"(max-width: 852px) 100vw, 852px\" \/><\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td class=\"notehead\"><\/td>\n<td><\/td>\n<td class=\"notehead\" colspan=\"4\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">The following table illustrates the reconciliation of the carrying value of level 3 assets from the beginning to the end of the year:<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\"><img decoding=\"async\" class=\"noteimage\" alt=\"\" src=\"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/p108.jpg\"><\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">There were no transfers between the different levels.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Level 3 investments consist mainly of investments in the Milestone China entities (Milestone), the Kagiso Infrastructure Empowerment Fund (KIEF) and the Pembani Remgro Infrastructure Fund (PRIF) amounting to R1 058 million, R322 million and R150 million respectively. These investments are all valued based on the fair value of each investment\u0092s underlying assets, which are valued using a variety of valuation methodologies. Listed entities are valued at the last quoted share price on the reporting date, whereas unlisted entities\u0092 methods include discounted cash flow valuations, appropriate earnings and revenue multiples.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Milestone\u0092&#8217;s fair value consists of listed investments (42%), cash and cash equivalents (4%) and unlisted investments (54%). Two-thirds of the unlisted investments were acquired during the current financial year and were valued at cost as Milestone\u0092s management considers the transaction price to be the fair value of the investments, while the remaining one-third was valued at approximately R190 million. KIEF\u0092&#8217;s investments were valued using the discounted cash flow method. PRIF\u0092&#8217;s main asset is the investment in ETG Group and it was valued using appropriate revenue and earnings multiples based on peer group companies to determine a price-to-book valuation.<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<td><\/td>\n<td colspan=\"4\">\n<p class=\"remove-indent\">Changes in the valuation assumptions of the above unlisted investments will not have a significant impact on Remgro\u0092&#8217;s financial statements.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>1. BASIS OF PREPARATION The summary consolidated financial statements are prepared in accordance with the requirements of the JSE Limited (JSE) for summary financial statements, and the requirements of the Companies Act applicable to summary financial statements. The JSE requires summary financial statements to be prepared in accordance with the framework concepts and the measurement&#8230;  <a href=\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/\" class=\"more-link\" title=\"Read Notes to the Financial Statements<br \/><small>FOR THE YEAR ENDED 30 JUNE 2015<\/small>&#8220;>Read more &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":10,"menu_order":92,"comment_status":"closed","ping_status":"closed","template":"page-full-width.php","meta":{"footnotes":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notes to the Financial StatementsFOR THE YEAR ENDED 30 JUNE 2015 - Remgro Limited<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notes to the Financial StatementsFOR THE YEAR ENDED 30 JUNE 2015 - Remgro Limited\" \/>\n<meta property=\"og:description\" content=\"1. BASIS OF PREPARATION The summary consolidated financial statements are prepared in accordance with the requirements of the JSE Limited (JSE) for summary financial statements, and the requirements of the Companies Act applicable to summary financial statements. The JSE requires summary financial statements to be prepared in accordance with the framework concepts and the measurement... Read more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/\" \/>\n<meta property=\"og:site_name\" content=\"Remgro Limited\" \/>\n<meta property=\"article:modified_time\" content=\"2015-10-16T16:46:35+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/\",\"url\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/\",\"name\":\"Notes to the Financial Statements FOR THE YEAR ENDED 30 JUNE 2015 - Remgro Limited\",\"isPartOf\":{\"@id\":\"https:\/\/www.remgro.com\/ar2015\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg\",\"datePublished\":\"2014-10-22T08:39:57+00:00\",\"dateModified\":\"2015-10-16T16:46:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#primaryimage\",\"url\":\"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg\",\"contentUrl\":\"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.remgro.com\/ar2015\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Financial report\",\"item\":\"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Notes to the Financial StatementsFOR THE YEAR ENDED 30 JUNE 2015\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.remgro.com\/ar2015\/#website\",\"url\":\"https:\/\/www.remgro.com\/ar2015\/\",\"name\":\"Remgro Limited\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.remgro.com\/ar2015\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notes to the Financial StatementsFOR THE YEAR ENDED 30 JUNE 2015 - Remgro Limited","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/","og_locale":"en_US","og_type":"article","og_title":"Notes to the Financial StatementsFOR THE YEAR ENDED 30 JUNE 2015 - Remgro Limited","og_description":"1. BASIS OF PREPARATION The summary consolidated financial statements are prepared in accordance with the requirements of the JSE Limited (JSE) for summary financial statements, and the requirements of the Companies Act applicable to summary financial statements. The JSE requires summary financial statements to be prepared in accordance with the framework concepts and the measurement... Read more &raquo;","og_url":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/","og_site_name":"Remgro Limited","article_modified_time":"2015-10-16T16:46:35+00:00","og_image":[{"url":"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg"}],"twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/","url":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/","name":"Notes to the Financial Statements FOR THE YEAR ENDED 30 JUNE 2015 - Remgro Limited","isPartOf":{"@id":"https:\/\/www.remgro.com\/ar2015\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#primaryimage"},"image":{"@id":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#primaryimage"},"thumbnailUrl":"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg","datePublished":"2014-10-22T08:39:57+00:00","dateModified":"2015-10-16T16:46:35+00:00","breadcrumb":{"@id":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#primaryimage","url":"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg","contentUrl":"http:\/\/www.remgro.com\/ar2015\/wp-content\/uploads\/img-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/notes-to-the-financial-statements\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.remgro.com\/ar2015\/"},{"@type":"ListItem","position":2,"name":"Financial report","item":"https:\/\/www.remgro.com\/ar2015\/index.php\/financial-report\/"},{"@type":"ListItem","position":3,"name":"Notes to the Financial StatementsFOR THE YEAR ENDED 30 JUNE 2015"}]},{"@type":"WebSite","@id":"https:\/\/www.remgro.com\/ar2015\/#website","url":"https:\/\/www.remgro.com\/ar2015\/","name":"Remgro Limited","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.remgro.com\/ar2015\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/pages\/1172"}],"collection":[{"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/comments?post=1172"}],"version-history":[{"count":0,"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/pages\/1172\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/pages\/10"}],"wp:attachment":[{"href":"https:\/\/www.remgro.com\/ar2015\/index.php\/wp-json\/wp\/v2\/media?parent=1172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}